IQCA1 antisense RNA 1 (IQCA1-AS1)

IQCA1 antisense RNA 1 (IQCA1-AS1) is a long non-coding RNA (lncRNA) transcribed in an antisense orientation relative to the IQCA1 gene. It is not a protein, receptor, enzyme, transporter, or traditional therapeutic target; rather, it is a **non-coding RNA** molecule that may play regulatory roles in gene expression and epigenetic regulation[3]. It has not been characterized as a direct therapeutic target, and there are no known drugs or clinical agents directly interacting with it. There is currently no strong evidence linking IQCA1-AS1 to a consistent function or pathological role, nor are there reports of its use as a disease biomarker or pharmacological target.\n\n**Note:**\n- IQCA1-AS1 should not be confused with IQCJ-SCHIP1-AS1, a different lncRNA for which disease associations (including tumor suppression in colorectal cancer) have been reported[2]. The two lncRNAs are distinct by genomic location, sequence, and function.\n- The information on IQCA1-AS1 is sparse, limited to basic gene annotation without experimentally validated functions, roles in disease, or actionable druggability data[3].\n\n**Summary:** IQCA1 antisense RNA 1 is a long non-coding antisense RNA with no known therapeutic relevance as of the current evidence, no direct links to disease, and no data supporting its use as a drug target or clinical biomarker[3].

Other names

IQCA1-AS1